AZMCX
Price
$19.96
Change
-$0.02 (-0.10%)
Updated
Dec 3 closing price
Net Assets
15.34M
RNWAX
Price
$92.44
Change
+$0.15 (+0.16%)
Updated
Dec 3 closing price
Net Assets
75.3B
Interact to see
Advertisement

AZMCX vs RNWAX

Header iconAZMCX vs RNWAX Comparison
Open Charts AZMCX vs RNWAXBanner chart's image
Virtus NFJ Emerging Markets Value C
Price$19.96
Change-$0.02 (-0.10%)
VolumeN/A
Net Assets15.34M
American Funds New World R1
Price$92.44
Change+$0.15 (+0.16%)
VolumeN/A
Net Assets75.3B
AZMCX vs RNWAX Comparison Chart in %
View a ticker or compare two or three
VS
AZMCX vs. RNWAX commentary
Dec 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZMCX is a StrongBuy and RNWAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RNWAX has more cash in the bank: 75.3B vs. AZMCX (15.3M). AZMCX pays higher dividends than RNWAX: AZMCX (0.85) vs RNWAX (0.00). AZMCX was incepted earlier than RNWAX: AZMCX (13 years) vs RNWAX (24 years). AZMCX (2.48) is less costly to investors than RNWAX (1.66). AZMCX is a more actively managed with annual turnover of: 119.00 vs. RNWAX (37.00). RNWAX has a lower initial minimum investment than AZMCX: RNWAX (250) vs AZMCX (2500). AZMCX annual gain was more profitable for investors over the last year : 27.23 vs. RNWAX (18.77). RNWAX return over 5 years is better than : 13.91 vs. AZMCX (2.61).
AZMCXRNWAXAZMCX / RNWAX
Total Expense Ratio1.891.66114%
Annual Report Gross Expense Ratio2.481.66149%
Fund Existence13 years24 years-
Gain YTD29.61025.547116%
Front LoadN/AN/A-
Min. Initial Investment25002501,000%
Min. Initial Investment IRAN/AN/A-
Net Assets15.3M75.3B0%
Annual Yield % from dividends0.850.00-
Returns for 1 year27.2318.77145%
Returns for 3 years35.4241.4685%
Returns for 5 years2.6113.9119%
Returns for 10 years67.5888.1577%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HRTX1.270.10
+8.55%
Heron Therapeutics
FCN165.030.60
+0.36%
FTI Consulting
CSR66.050.24
+0.36%
Centerspace
GLW83.55-0.16
-0.19%
Corning
CLGN2.07-0.07
-3.39%
CollPlant Biotechnologies Ltd